1720 — Standard Chem & Pharm Co Share Price
- TWD11.78bn
- TWD13.67bn
- TWD6.24bn
- 80
- 59
- 74
- 87
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.22 | ||
Price to Tang. Book | 2.32 | ||
Price to Free Cashflow | 16.63 | ||
Price to Sales | 1.89 | ||
EV to EBITDA | 8.28 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 14.77% | ||
Return on Equity | 16.61% | ||
Operating Margin | 20.87% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | TWDm | 3,937.13 | 4,305.4 | 4,604.08 | 5,851.37 | 6,239.77 | n/a | n/a | 11.8% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +2.24 | +36.59 | +23.46 | +26.98 | -2.73 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Standard Chemical & Pharmaceutical Co. Ltd. is a Taiwan-based company principally engaged in the manufacture and sales of western pharmaceuticals, dietary supplement and active pharmaceutical ingredients. The Company’s products cover drugs for circulation systems, digest systems, respiratory systems, nervous systems and other diseases. Through its subsidiaries, the Company is also engaged in the sales of medical equipment, animal medicine, milk powder, cosmetics and others. The Company distributes its products both in domestic markets and overseas markets.
Directors
- Jincai Fan CHM
- Ziting Fan GMG
- Weiren Chen DGM
- Wenzhang Lin DGM
- Ruihong Xu OTH
- Yuande Li DRC
- Juncai Qiu DRC
- Zhenming Xiao DRC
- Cuiwen Ye DRC
- Linyu Li IND
- Shaozong Liu IND
- Huijun Wang IND
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- June 30th, 1967
- Public Since
- December 12th, 1995
- No. of Employees
- 1,130
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Taiwan Stock Exchange
- Shares in Issue
- 178,696,000
- Address
- No.6-20, TAINAN, 730
- Web
- https://www.standard.com.tw/
- Phone
- +886 66361516
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for 1720
Q1 2024 Standard Chem & Pharm Co Ltd Earnings Release
April 2024 Standard Chem & Pharm Co Ltd Corporate Sales Release
May 2024 Standard Chem & Pharm Co Ltd Corporate Sales Release
Standard Chem & Pharm Co Ltd Annual Shareholders Meeting
June 2024 Standard Chem & Pharm Co Ltd Corporate Sales Release
July 2024 Standard Chem & Pharm Co Ltd Corporate Sales Release
Q2 2024 Standard Chem & Pharm Co Ltd Earnings Release
August 2024 Standard Chem & Pharm Co Ltd Corporate Sales Release
Similar to 1720
Adimmune
Taiwan Stock Exchange
Bora Pharmaceuticals Co
Taiwan Stock Exchange
China Chemical & Pharmaceutical Co
Taiwan Stock Exchange
Chunghwa Chemical Synthesis & Biotech Co
Taiwan Stock Exchange
Formosa Laboratories
Taiwan Stock Exchange
FAQ
As of Today at 18:19 UTC, shares in Standard Chem & Pharm Co are trading at TWD65.90. This share price information is delayed by 15 minutes.
Shares in Standard Chem & Pharm Co last closed at TWD65.90 and the price had moved by +22.72% over the past 365 days. In terms of relative price strength the Standard Chem & Pharm Co share price has outperformed the FTSE Developed Asia Pacific Index by +16.33% over the past year.
The overall consensus recommendation for Standard Chem & Pharm Co is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Standard Chem & Pharm Co dividend yield is 4.1% based on the trailing twelve month period.
Last year, Standard Chem & Pharm Co paid a total dividend of TWD2.70, and it currently has a trailing dividend yield of 4.1%. We do not have any data on when Standard Chem & Pharm Co is to next pay dividends.
We do not have data on when Standard Chem & Pharm Co is to next pay dividends. The historic dividend yield on Standard Chem & Pharm Co shares is currently 4.1%.
To buy shares in Standard Chem & Pharm Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of TWD65.90, shares in Standard Chem & Pharm Co had a market capitalisation of TWD11.78bn.
Here are the trading details for Standard Chem & Pharm Co:
- Country of listing: Taiwan
- Exchange: TAI
- Ticker Symbol: 1720
Based on an overall assessment of its quality, value and momentum Standard Chem & Pharm Co is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Standard Chem & Pharm Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -7.73%.
As of the last closing price of TWD65.90, shares in Standard Chem & Pharm Co were trading +0.81% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Standard Chem & Pharm Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at TWD65.90.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Standard Chem & Pharm Co's management team is headed by:
- Jincai Fan - CHM
- Ziting Fan - GMG
- Weiren Chen - DGM
- Wenzhang Lin - DGM
- Ruihong Xu - OTH
- Yuande Li - DRC
- Juncai Qiu - DRC
- Zhenming Xiao - DRC
- Cuiwen Ye - DRC
- Linyu Li - IND
- Shaozong Liu - IND
- Huijun Wang - IND